U.S. Department of Health & Human[...]
As American Families Prepare for Back-to-School, Biden-Harris[...]
U.S. Department of Health & Human[...]
HHS Facilitates Agreement to Accelerate Delivery of Additional Smallpox[...]
Clarus Therapeutics Holdings Inc.
Costs Associated with Exit or Disposal Activities - Form 8-K
07/06/2022 | Press release | Distributed by Public on 07/06/2022 18:57
Please select the service you want to use:
Smartlinks | Day One Biopharmaceuticals Inc. | News | Health | Local News | Finance | Security Markets | Derivative Securities | Security Markets | Company News | Shareholders | Buyback, Treasury Shares and Liquidity Agreements | Internal Dealings | Public Companies | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact